Aminoglycosides (AGs) are broad-spectrum antibiotics that play an important role in the control and treatment of bacterial infections. Despite the great antibacterial potency of AGs, resistance to these antibiotics has limited their clinical applications. The AG 3′-O-phosphotransferase of type IIa (APH(3′)-IIa) encoded by the neoR gene is a common bacterial AG resistance enzyme that inactivates AG antibiotics. This enzyme is used as a selection marker in molecular biology research. APH(3′)-IIa catalyzes the transfer of the γ-phosphoryl group of ATP to an AG at its 3′-OH group. Although APH(3′)-IIa has been reported to utilize exclusively ATP as a cosubstrate, we demonstrate that this enzyme can utilize a broad array of NTPs. By substrate profiling, TLC, and enzyme kinetics experiments, we probe AG phosphorylation by APH(3′)-IIa with an extensive panel of substrates and cosubstrates (13 AGs and 10 NTPs) for the purpose of gaining a thorough understanding of this resistance enzyme. We find, for the first time, that the identity of the NTP cosubstrate dictates the set of AGs modified by APH(3′)-IIa and the phosphorylation efficiency for different AGs.
|Number of pages||8|
|State||Published - 2018|
Bibliographical noteFunding Information:
This work was supported by a grant from the National Institutes of Health (NIH AI090048) (to S.G.-T.).
© The Royal Society of Chemistry.
ASJC Scopus subject areas
- Molecular Medicine
- Pharmaceutical Science
- Drug Discovery
- Organic Chemistry